Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.23), $0.43 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.